Severe and continuous immunoparesis during induction or maintenance therapy in nontransplant patients with multiple myeloma is a sign of poor prognosis

Severe and continuous immunoparesis during induction or maintenance therapy in nontransplant patients with multiple myeloma is a sign of poor prognosis

ABSTRACTObjective Multiple myeloma (MM) varies in clinical behavior, response to treatment and prognosis due to the heterogeneity of the disease. Data on the association between the immunoparesis status during treatment and prognosis in nontransplant MM patients are limited.Methods In a retrospectiv...

Full description

Bibliographic Details
Main Authors: Ying Chen, Zhe Chen, Junjie Cao, Li Lin, Jipeng Li
Format: Article
Language:English
Published: Taylor & Francis Group 2024-12-01
Series:Hematology
Subjects:
severe and continuous immunoparesis
multiple myeloma
treatment
survival
response
Online Access:https://www.tandfonline.com/doi/10.1080/16078454.2024.2329378

Internet

https://www.tandfonline.com/doi/10.1080/16078454.2024.2329378

Similar Items